Selank research centers on a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the endogenous immunomodulatory tetrapeptide tuftsin. First characterized at the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank has become a frequent subject of preclinical investigation into anxiolytic and immunomodulatory mechanisms. This guide summarizes the receptor systems, signaling pathways, and research models that scientists have used to study the peptide in laboratory settings.
Research Use Only. Selank and all peptides referenced here are supplied strictly for laboratory research use only. They are not for human or veterinary use, have not been evaluated by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing below is medical advice or a dosing protocol. All statements describe mechanisms and published experimental findings in in-vitro and animal models.
What Is Selank?
Selank is a stabilized analog of tuftsin, a naturally occurring fragment of the immunoglobulin G heavy chain. To the tuftsin core (Thr-Lys-Pro-Arg) researchers appended a Pro-Gly-Pro tripeptide tail. This C-terminal extension is the structural feature that gives Selank its comparatively long duration of action in research preparations: the proline-rich terminus resists rapid enzymatic cleavage by aminopeptidases and carboxypeptidases, extending the peptide's measurable half-life relative to unmodified tuftsin, which is degraded within minutes.
Key physicochemical properties studied
- Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (heptapeptide)
- Molecular formula: CₕₖH₉₄N₁₆O₁₀ (~751 g/mol)
- Parent molecule: tuftsin (immunomodulatory IgG fragment)
- Solubility: water-soluble; commonly reconstituted with bacteriostatic or sterile water for laboratory assays
- Investigated formats: lyophilized powder for in-vitro work; intranasal preparations in animal models
GABAergic and Anxiolytic Mechanisms Under Investigation
The most studied property of Selank is its apparent anxiolytic-like activity in rodent behavioral paradigms, without the sedation, motor impairment, or dependence liability associated with benzodiazepine-class GABA-A positive allosteric modulators. Research suggests the peptide engages the GABAergic system indirectly rather than binding the benzodiazepine site directly.
Proposed GABA-linked pathways
In preclinical models, investigators have examined several converging mechanisms:
- GABA-A modulation: Studies have reported that Selank influences expression of GABA-A receptor subunits and alters the affinity profile of GABA binding in cortical and hippocampal tissue, consistent with an anxiolytic-like phenotype.
- Monoamine balance: Research models show effects on serotonergic and dopaminergic turnover, including modulation of serotonin metabolism and monoamine oxidase activity, which are implicated in emotional-behavioral regulation.
- Enkephalinase inhibition: Selank has been reported to inhibit degradation of enkephalins by leucine enkephalinase, prolonging endogenous opioid-peptide signaling that may contribute to its behavioral profile.
- BDNF expression: In hippocampal studies, exposure has been associated with changes in brain-derived neurotrophic factor (BDNF) mRNA, linking the peptide to neuroplasticity pathways also explored for its structural cousin, Semax.
For a deeper mechanistic treatment of the receptor-level story, see our companion article on Selank, tuftsin, and GABA anxiolytic mechanisms.
Immunomodulatory Pathways
Because Selank descends from tuftsin — a peptide whose native role is stimulating phagocytosis and immune signaling — a substantial body of research has examined its immunomodulatory effects. This dual anxiolytic/immunomodulatory character is what makes the molecule distinctive among nootropic research peptides.
- Cytokine modulation: Animal studies have reported that Selank shifts the balance of pro- and anti-inflammatory cytokines, including effects on interleukin-6 (IL-6) and interferon expression.
- Th1/Th2 regulation: Research has examined the peptide's capacity to modulate the helper T-cell cytokine balance, a mechanism relevant to models of stress-associated immune dysregulation.
- Gene-expression effects: Transcriptomic studies in rodent spleen and brain tissue have documented broad changes in genes tied to immune response and inflammation following administration.
The intersection of GABAergic and immune signaling is an active area of neuroimmunology research, and Selank is frequently used as a probe compound in these experimental designs.
Selank in the Nootropic Peptide Landscape
Selank is often studied alongside Semax, another Russian-developed regulatory peptide. While both are investigated for cognitive and neuroprotective endpoints, their mechanistic emphases differ: Semax research skews toward BDNF/melanocortin and dopaminergic pathways, whereas Selank research emphasizes GABAergic tone and anxiolytic behavior. Our Semax vs Selank comparison maps these differences in detail, and the Semax research guide covers the BDNF story on its own terms.
| Attribute | Selank | Semax |
|---|---|---|
| Parent molecule | Tuftsin (IgG fragment) | ACTH(4-10) fragment |
| Primary research emphasis | Anxiolytic / GABAergic | Nootropic / neurotrophic |
| Key pathway studied | GABA-A, monoamines, enkephalins | BDNF, melanocortin, dopamine |
| Immunomodulation | Prominent (tuftsin-derived) | Secondary |
Laboratory Handling and Reconstitution
The following notes describe handling of Selank as a research preparation only. They are laboratory procedures, not usage instructions for any organism.
- Storage (lyophilized): Stable stored cool and dry, protected from light; long-term storage at -20°C preserves peptide integrity.
- Reconstitution: Sterile or bacteriostatic water is typically used to bring lyophilized powder into solution for assay work; gentle swirling avoids shear degradation.
- Reconstituted stability: Aqueous solutions are best held refrigerated (2–8°C) and used within a limited window; aliquoting minimizes freeze-thaw cycles.
- Purity verification: Every NeuroLabs research preparation ships with a third-party Certificate of Analysis documenting ≥99% purity by HPLC and mass-spec identity.
Intranasal research formats are a common experimental route for this peptide class because they bypass first-pass metabolism; see our Selank nasal spray intranasal research format guide for that discussion. Researchers examining sleep-architecture endpoints alongside anxiolytic work often cross-reference the DSIP research guide.
Featured Research Peptide
NeuroLabs supplies Selank 10mg as a lyophilized, COA-verified research preparation (≥99% purity) with same-day USA shipping. This product is intended for laboratory research use only. Explore the full Cognitive & Nootropic Research Peptides pillar for related compounds and mechanisms.